Residual tumor volume versus extent of resection: predictors of survival after surgery for glioblastoma.
about
Current trends in the surgical management and treatment of adult glioblastomaOvercoming therapeutic resistance in glioblastoma: the way forwardSurvival in glioblastoma: a review on the impact of treatment modalities.The value of extent of resection of glioblastomas: clinical evidence and current approach.Strategy of Surgical Resection for Glioma Based on Intraoperative Functional Mapping and Monitoring.Extent of Endoscopic Resection for Anterior Skull Base Tumors: An MRI-Based Volumetric Analysis.Modified Criteria for Radiographic Response Assessment in Glioblastoma Clinical Trials.Growth dynamics of untreated glioblastomas in vivo.Fully Automated Enhanced Tumor Compartmentalization: Man vs. Machine Reloaded.Quantitative MRI for analysis of peritumoral edema in malignant gliomasMean apparent diffusion coefficient values in defining radiotherapy planning target volumes in glioblastoma.Complete resection of contrast-enhancing tumor volume is associated with improved survival in recurrent glioblastoma-results from the DIRECTOR trialClinical Evaluation of a Fully-automatic Segmentation Method for Longitudinal Brain Tumor Volumetry.Semi-Automated Volumetric and Morphological Assessment of Glioblastoma Resection with Fluorescence-Guided SurgerySupra-complete surgery via dual intraoperative visualization approach (DiVA) prolongs patient survival in glioblastomaLong-term survival in glioblastoma: methyl guanine methyl transferase (MGMT) promoter methylation as independent favourable prognostic factor.Infarct volume after glioblastoma surgery as an independent prognostic factor.Long-term outcomes of concomitant chemoradiotherapy with temozolomide for newly diagnosed glioblastoma patients: A single-center analysis.Managing teenage/young adult (TYA) brain tumors: a UK perspective.Volumetric quantification of glioblastoma: experiences with different measurement techniques and impact on survival.Phase II multicenter study of gene-mediated cytotoxic immunotherapy as adjuvant to surgical resection for newly diagnosed malignant gliomaPatient-Specific Resection Strategy of Glioblastoma Multiforme: Choice Based on a Preoperative Scoring Scale.Dynamics of FLAIR Volume Changes in Glioblastoma and Prediction of Survival.Aberrant Wnt signaling: a special focus in CNS diseases.Surgical Considerations in the Optimal Management of Patients with Malignant Brain Tumors.Impact of removed tumor volume and location on patient outcome in glioblastoma.Baseline pretreatment contrast enhancing tumor volume including central necrosis is a prognostic factor in recurrent glioblastoma: evidence from single and multicenter trials.ACRIN 6684: Assessment of Tumor Hypoxia in Newly Diagnosed Glioblastoma Using 18F-FMISO PET and MRI.Improved Survival with Decreased Wait Time to Surgery in Glioblastoma Patients Presenting with Seizure.Effect of 10 different polymorphisms on preoperative volumetric characteristics of glioblastoma multiforme.Modeling the efficacy of the extent of surgical resection in the setting of radiation therapy for glioblastoma.The benefit of surgical resection in recurrent glioblastoma.Prognostic Value of Tumor Volume in Glioblastoma Patients: Size Also Matters for Patients with Incomplete Resection.Evidence and Context of Use for Contrast Enhancement as a Surrogate of Disease Burden and Treatment Response in Malignant Glioma.Role of Glioblastoma Craniotomy Related to Patient Survival: A 10-Year Survey in a Tertiary Care Hospital in Pakistan.Accurate Delineation of Glioma Infiltration by Advanced PET/MR Neuro-Imaging (FRONTIER Study): A Diagnostic Study Protocol.Impact on Radiation Dose and Volume V57 Gy of the Brain on Recurrence and Survival of Patients with Glioblastoma Multiformae.Results of a multicenter survey showing interindividual variability among neurosurgeons when deciding on the radicality of surgical resection in glioblastoma highlight the need for more objective guidelines.Maximize surgical resection beyond contrast-enhancing boundaries in newly diagnosed glioblastoma multiforme: is it useful and safe? A single institution retrospective experience.Is a pretreatment radiological staging system feasible for suggesting the optimal extent of resection and predicting prognosis in glioblastoma? An observational study.
P2860
Q26799854-5DA76534-4555-4FBD-9BB8-5B51C0C3643FQ29248396-64B9758F-4DDB-41D0-9F7D-0B8EECBE7E52Q30251810-D68BD686-C27A-4914-9809-5D5B67225478Q30873962-E7E9A52C-BDD1-4F97-B888-F68F48E230D7Q30981108-DB94303A-727D-43C8-8EFF-F6E5E6673861Q33276530-ECBD4B33-D878-480A-9040-B7B57B2A7A38Q33586021-1F7672B2-5842-4E59-8FE5-405A249115BBQ36082476-9CA5B6B5-BCD3-40F1-8AEF-E02E7A584897Q36180449-99218B2F-50C3-4B8A-AFE1-4A31A9761405Q36380888-062C068D-3EB9-4551-8395-1C395CE99165Q36427409-B4CBA250-C9E3-43D3-BD79-E90FFCB989B0Q36705933-0892FA9A-5D8F-49A0-9BED-CD36A3BBEE39Q36713514-9FCA9F0A-4840-4F3E-B163-2E14979CF4A8Q36889298-3626AF23-EB09-4AF5-83D6-E1B2A623435AQ37295485-501D388E-A6B7-42A9-B868-C8D5FECE7D5BQ37432015-1698A8DF-940C-4BED-830C-A788D51A73EEQ37641715-BA5027C6-EE21-4851-80DE-2FCB445867B9Q38401359-AEADAE50-6DEC-46A8-B82D-3ED7836E9F99Q38539466-AC46DEBD-1CC5-47AF-9002-2E46ADA20A09Q38654095-C0E41A2E-5671-4B48-BF23-E45B563ED573Q38912327-1519FF7F-3D79-414F-8A33-10F7AF97ED4DQ39189199-97338080-25C8-4DE9-82F2-BDA64646ACF0Q39264053-0B3D059C-A18F-465D-97F0-A4D765328B7CQ39387696-BDDA052F-9C80-4E3B-B7C0-CF56FC5B5E7DQ39417263-A6855423-AFE1-4074-A8B1-DD752869575FQ39420029-B7F8AD08-3D08-4076-9702-C11E1BCD13E6Q39435280-084AF62C-4786-4008-987B-2C6B916B4D16Q39761792-ECF9B26B-6E89-458D-8C55-4C80241C0E3AQ40186790-8E559F65-DD01-4570-96E2-2DD4A010E471Q40279363-9826CE1B-00B4-4461-8499-8A102DC37CEDQ42008851-48D6D779-C08E-4341-A0E7-AEFCDC286B79Q42944471-6C55F8C6-B5E2-41F1-90DF-5513E8170C88Q47175955-315B6240-97A7-4009-B879-4E4DF55D7D61Q47436703-F6491506-F4DD-4889-A19A-334014068BA7Q47569617-E18EDCFC-A366-4C91-855C-D86FEF8EE018Q47726661-6021C4E6-6CC5-483B-9379-9BE877D6A189Q47864874-4B5CB25B-335A-4A42-ABE6-6D80FE512937Q48124819-60DFE318-4480-4193-A396-9EA929E53F42Q48156165-0BD07F32-6251-41D9-87AC-AD36DB23DC03Q48334378-4491900B-7CA9-4F0F-8109-FE9C01A35916
P2860
Residual tumor volume versus extent of resection: predictors of survival after surgery for glioblastoma.
description
2014 nî lūn-bûn
@nan
2014 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Residual tumor volume versus e ...... fter surgery for glioblastoma.
@ast
Residual tumor volume versus e ...... fter surgery for glioblastoma.
@en
type
label
Residual tumor volume versus e ...... fter surgery for glioblastoma.
@ast
Residual tumor volume versus e ...... fter surgery for glioblastoma.
@en
prefLabel
Residual tumor volume versus e ...... fter surgery for glioblastoma.
@ast
Residual tumor volume versus e ...... fter surgery for glioblastoma.
@en
P2093
P356
P1476
Residual tumor volume versus e ...... fter surgery for glioblastoma.
@en
P2093
Amy S Nowacki
Jason L Schroeder
Lilyana Angelov
Matthew M Grabowski
Michael A Vogelbaum
Pablo F Recinos
P304
P356
10.3171/2014.7.JNS132449
P577
2014-09-05T00:00:00Z